Pharmacokinetics and Pharmacodynamics of Low Dose Mycophenolate Mofetil in HIV-Infected Patients Treated with Abacavir, Efavirenz and Nelfinavir

被引：0
|
作者：
Olga Millán
Mercé Brunet
Jaume Martorell
Felipe García
Elena Vidal
Isabel Rojo
Montserrat Plana
Teresa Gallart
Tomas Pumarola
Jose M. Miró
Jose M. Gatell
机构：
[1] Universitat de Barcelona,Servei Immunologia, Hospital Clínic, IDIBAPS
[2] Universitat de Barcelona,Servei Toxicologia, Hospital Clínic, IDIBAPS
[3] Universitat de Barcelona,Servei Infeccions, Hospital Clínic, IDIBAPS
[4] Universitate de Barcelona,Servei Microbiologia, Hospital Clínic, IDIBAPS
[5] Hospital Clinic de Barcelona,Servei Immunologia
来源：
Clinical Pharmacokinetics | 2005年 / 44卷
关键词：
Viral Load; Efavirenz; Mycophenolate Mofetil; Abacavir; Mycophenolic Acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：525 / 538
页数：13
相关论文
共 50 条
  • [1] Pharmacokinetics and pharmaco dynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavir
    Millán, O
    Brunet, M
    Martorell, J
    García, F
    Vidal, E
    Rojo, I
    Plana, M
    Gallart, T
    Pumarola, T
    Miró, JM
    Gatell, JM
    CLINICAL PHARMACOKINETICS, 2005, 44 (05) : 525 - 538
  • [2] Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trial
    Fletcher, C. V.
    Brundage, R. C.
    Fenton, T.
    Alvero, C. G.
    Powell, C.
    Mofenson, L. M.
    Spector, S. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) : 300 - 306
  • [3] Efavirenz dose reduction in HIV-infected patients
    Vento, S.
    Lanzafame, M.
    Lattuada, E.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 : 80 - 81
  • [4] Efavirenz dose reduction in HIV-infected patients
    Lanzafame, M.
    Bonora, S.
    Lattuada, E.
    Vento, S.
    HIV MEDICINE, 2012, 13 (04) : 252 - 253
  • [5] Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients
    Burger, D
    Boyd, M
    Duncombe, C
    Felderhof, M
    Mahanontharit, A
    Ruxrungtham, K
    Ubolyam, S
    Stek, M
    Cooper, D
    Lange, J
    Phanupak, P
    Reiss, P
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (05) : 1231 - 1238
  • [6] Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients
    Sriwiriyajan, Somchai
    Mahatthanatrakul, Werawath
    Ridtitid, Wibool
    Jaruratanasirikul, Sutep
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (05) : 479 - 483
  • [7] Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients
    Somchai Sriwiriyajan
    Werawath Mahatthanatrakul
    Wibool Ridtitid
    Sutep Jaruratanasirikul
    European Journal of Clinical Pharmacology, 2007, 63 : 479 - 483
  • [8] Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients
    Merry, C
    Barry, MG
    Mulcahy, F
    Halifax, KL
    Back, DJ
    AIDS, 1997, 11 (15) : F117 - F120
  • [9] Clinical pharmacokinetics of nelfinavir combined with efavirenz and stavudine during rescue treatment of heavily pretreated HIV-infected patients
    Regazzi, MB
    Villani, P
    Maserati, R
    Seminari, E
    Pan, A
    LoCaputo, F
    Gambarana, E
    Fiocchi, C
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (03) : 343 - 347
  • [10] Weight related differences in the pharmacokinetics of abacavir in HIV-infected patients
    Jullien, V
    Tréluyer, JM
    Chappuy, H
    Dimet, J
    Rey, E
    Dupin, N
    Salmon, D
    Pons, G
    Urien, S
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (02) : 183 - 188
12345